164 related articles for article (PubMed ID: 35158121)
1. Genomic landscape of secretory carcinoma of the breast with axillary lymph node metastasis.
Chen M; Pu T; Wei B; Bu H; Tang P; Zhang Z
Pathol Res Pract; 2022 Mar; 231():153790. PubMed ID: 35158121
[TBL] [Abstract][Full Text] [Related]
2. Pan-tropomyosin receptor kinase immunoreactivity, ETV6-NTRK3 fusion subtypes, and RET rearrangement in salivary secretory carcinoma.
Yamamoto H; Nozaki Y; Sugii A; Taguchi K; Hongo T; Jiromaru R; Sato M; Nakano T; Hashimoto K; Fujiwara M; Oda Y
Hum Pathol; 2021 Mar; 109():37-44. PubMed ID: 33301751
[TBL] [Abstract][Full Text] [Related]
3. Secretory carcinoma of the breast: clinicopathologic profile of 14 cases emphasising distant metastatic potential.
Hoda RS; Brogi E; Pareja F; Nanjangud G; Murray MP; Weigelt B; Reis-Filho JS; Wen HY
Histopathology; 2019 Aug; 75(2):213-224. PubMed ID: 31012486
[TBL] [Abstract][Full Text] [Related]
4. Secretory Carcinoma with ETV6-NTRK3 Gene Fusion and Lymph Node Metastasis in Maxillary Gingiva: A Case Report with Pathological and Molecular Correlative Studies.
Fujita J; Krishnan B; Green LK; Sandulache VC; Lai S
Ann Clin Lab Sci; 2023 Sep; 53(5):800-805. PubMed ID: 37945013
[TBL] [Abstract][Full Text] [Related]
5. Secretory Breast Carcinoma: A Histopathologic and Genomic Spectrum Characterized by a Joint Specific ETV6-NTRK3 Gene Fusion.
Del Castillo M; Chibon F; Arnould L; Croce S; Ribeiro A; Perot G; Hostein I; Geha S; Bozon C; Garnier A; Lae M; Vincent-Salomon A; MacGrogan G
Am J Surg Pathol; 2015 Nov; 39(11):1458-67. PubMed ID: 26291510
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathological features and genomic profiles of a group of secretory breast carcinomas in which progressive cases have more complex genomic features.
Lei T; Yang Y; Shi Y; Deng X; Peng Y; Wang H; Chen T
Diagn Pathol; 2022 Dec; 17(1):101. PubMed ID: 36585729
[TBL] [Abstract][Full Text] [Related]
7. Genomic profiling of breast secretory carcinomas reveals distinct genetics from other breast cancers and similarity to mammary analog secretory carcinomas.
Krings G; Joseph NM; Bean GR; Solomon D; Onodera C; Talevich E; Yeh I; Grenert JP; Hosfield E; Crawford ED; Jordan RC; van Zante A; Zaloudek C; Shin SJ; Chen YY
Mod Pathol; 2017 Aug; 30(8):1086-1099. PubMed ID: 28548128
[TBL] [Abstract][Full Text] [Related]
8. Clinical and Morphologic Features of ETV6-NTRK3 Translocated Papillary Thyroid Carcinoma in an Adult Population Without Radiation Exposure.
Seethala RR; Chiosea SI; Liu CZ; Nikiforova M; Nikiforov YE
Am J Surg Pathol; 2017 Apr; 41(4):446-457. PubMed ID: 28125451
[TBL] [Abstract][Full Text] [Related]
9. Nuclear staining for pan-Trk by immunohistochemistry is highly specific for secretory carcinoma of breast: pan-Trk in various subtypes of breast carcinoma.
Ye Q; Chen H; Han C; Peng Y; Huang X; Sun H; Wu Y; Albarracin CT; Middleton LP; Sahin AA; Huo L; Ding Q
J Clin Pathol; 2023 Aug; ():. PubMed ID: 37586834
[TBL] [Abstract][Full Text] [Related]
10. Secretory breast carcinomas with ETV6-NTRK3 fusion gene belong to the basal-like carcinoma spectrum.
Laé M; Fréneaux P; Sastre-Garau X; Chouchane O; Sigal-Zafrani B; Vincent-Salomon A
Mod Pathol; 2009 Feb; 22(2):291-8. PubMed ID: 19011601
[TBL] [Abstract][Full Text] [Related]
11. Atypical/unbalanced ETV6/NTRK3 rearrangement in salivary secretory carcinoma with a focus on the incidence, the patterns, and the clinical implications.
Sun J; Li J; Tian Z; Zhang C; Xia R; He Y
J Oral Pathol Med; 2022 Sep; 51(8):721-729. PubMed ID: 36087274
[TBL] [Abstract][Full Text] [Related]
12. Pan-TRK Immunohistochemistry: A Useful Diagnostic Adjunct For Secretory Carcinoma of the Breast.
Harrison BT; Fowler E; Krings G; Chen YY; Bean GR; Vincent-Salomon A; Fuhrmann L; Barnick SE; Chen B; Hosfield EM; Hornick JL; Schnitt SJ
Am J Surg Pathol; 2019 Dec; 43(12):1693-1700. PubMed ID: 31498178
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathological investigation of secretory carcinoma cases including a successful treatment outcome using entrectinib for high-grade transformation: a case report.
Suzuki K; Harada H; Takeda M; Ohe C; Uemura Y; Kawahara A; Sawada S; Kanda A; Sengupta B; Iwai H
BMC Med Genomics; 2022 Jan; 15(1):6. PubMed ID: 34991563
[TBL] [Abstract][Full Text] [Related]
14. Additional Nodal Disease Prediction in Breast Cancer with Sentinel Lymph Node Metastasis Based on Clinicopathological Features.
Orsaria P; Caredda E; Genova F; Materazzo M; Capuano I; Vanni G; Granai AV; DE Majo A; Portarena I; Sileri P; Petrella G; Palombi L; Buonomo OC
Anticancer Res; 2018 Apr; 38(4):2109-2117. PubMed ID: 29599329
[TBL] [Abstract][Full Text] [Related]
15. The Case to Case Comparison of Hormone Receptors and HER2 Status between Primary Breast Cancer and Synchronous Axillary Lymph Node Metastasis.
Sujarittanakarn S; Himakhun W; Worasawate W; Prasert W
Asian Pac J Cancer Prev; 2020 Jun; 21(6):1559-1565. PubMed ID: 32592349
[TBL] [Abstract][Full Text] [Related]
16. Correlation Between Raf/MEK/ERK Signaling Pathway and Clinicopathological Features and Prognosis for Patients With Breast Cancer Having Axillary Lymph Node Metastasis.
Shao GL; Wang MC; Fan XL; Zhong L; Ji SF; Sang G; Wang S
Technol Cancer Res Treat; 2018 Jan; 17():1533034617754024. PubMed ID: 29529946
[TBL] [Abstract][Full Text] [Related]
17. Solid papillary carcinoma of the breast: A special entity needs to be distinguished from conventional invasive carcinoma avoiding over-treatment.
Guo S; Wang Y; Rohr J; Fan C; Li Q; Li X; Wang Z
Breast; 2016 Apr; 26():67-72. PubMed ID: 27017244
[TBL] [Abstract][Full Text] [Related]
18. Association between axillary lymph node status and Ki67 labeling index in triple-negative medullary breast carcinoma.
Chu Z; Lin H; Liang X; Huang R; Tang J; Bao Y; Jiang J; Zhan Q; Zhou X
Jpn J Clin Oncol; 2015 Jul; 45(7):637-41. PubMed ID: 25862826
[TBL] [Abstract][Full Text] [Related]
19. Secretory carcinoma of the breast, commonly exhibits the features of low grade, triple negative breast carcinoma- A Case report with updated review of literature.
Banerjee N; Banerjee D; Choudhary N
Autops Case Rep; 2021; 11():e2020227. PubMed ID: 34277491
[TBL] [Abstract][Full Text] [Related]
20. A Case of Primary Mammary Analog Secretory Carcinoma (MASC) of the Thyroid Masquerading as Papillary Thyroid Carcinoma: Potentially More than a One Off.
Reynolds S; Shaheen M; Olson G; Barry M; Wu J; Bocklage T
Head Neck Pathol; 2016 Sep; 10(3):405-13. PubMed ID: 27075025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
